benzgalantamine

FDA Drug Profile — ZUNVEYL

Drug Details

Generic Name
benzgalantamine
Brand Names
ZUNVEYL
Application Number
NDA218549
Sponsor
Alpha Cognition, Inc.
NDC Codes
3
Dosage Forms
TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients
BENZGALANTAMINE

Indications and Usage

1 INDICATIONS AND USAGE ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults. ZUNVEYL is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults ( 1 )